Evidence map›Paper›PMID 8807400›Full record

ReviewJournal of bioenergetics and biomembranes1996

High-conductance calcium-activated potassium channels; structure, pharmacology, and function.

G J Kaczorowski, H G Knaus, R J Leonard, O B McManus, M L Garcia

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of bioenergetics and biomembranes, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 300 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Future targets for migraine treatment beyond CGRP.The journal of headache and pain · 2023
    Review
  5. Generation of Alternate Indole Diterpene Architectures in Two Species ofJournal of the American Chemical Society · 2023
    Article
  6. Article
  7. Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Chloroform Extract ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

G J KaczorowskiMerck Research Laboratories, Rahway, New Jersey 07065, USA.
H G Knaus
R J Leonard
O B McManus
M L Garcia
Merck & Co., Inc., Rahway, NJ, USA (United States) · USUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-conductance calcium-activated potassium (maxi-K) channels comprise a specialized family of K+ channels. They are unique in their dual requirement for depolarization and Ca2+ binding for transition to the open, or conducting, state. Ion conduction through maxi-K channels is blocked by a family of venom-derived peptides, such as charybdotoxin and iberiotoxin. These peptides have been used to study function and structure of maxi-K channels, to identify novel channel modulators, and to follow the purification of functional maxi-K channels from smooth muscle. The channel consists of two dissimilar subunits, alpha and beta. The alpha subunit is a member of the slo Ca(2+)-activated K+ channel gene family and forms the ion conduction pore. The beta subunit is a structurally unique, membrane-spanning protein that contributes to channel gating and pharmacology. Potent, selective maxi-K channel effectors (both agonists and blockers) of low molecular weight have been identified from natural product sources. These agents, together with peptidyl inhibitors and site-directed antibodies raised against alpha and beta subunit sequences, can be used to anatomically map maxi-K channel expression, and to study the physiologic role of maxi-K channels in various tissues. One goal of such investigations is to determine whether maxi-K channels represent novel therapeutic targets.

Indexed as

Potassium Channels, Calcium-ActivatedAmino Acid SequenceAnimalsCharybdotoxinDiterpenesGlycosylationLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsLarge-Conductance Calcium-Activated Potassium Channel beta SubunitsLarge-Conductance Calcium-Activated Potassium ChannelsModels, MolecularMolecular Sequence DataMuscle, SmoothPeptidesPotassium ChannelsProtein ConformationScorpion VenomsCharybdotoxinDiterpenesiberiotoxinLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsLarge-Conductance Calcium-Activated Potassium Channel beta SubunitsLarge-Conductance Calcium-Activated Potassium ChannelsmaxikdiolPeptidesPotassium ChannelsPotassium Channels, Calcium-ActivatedScorpion VenomsTriterpenes

Identifiers

PMID8807400
OpenAlexW2021958245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.